• Your local doctor might not get access to the COVID-19 vaccine - here's why

    15 days ago - By Business Insider

    Healthcare workers get the Pfizer-BioNTech COVID-19 vaccination at the Legacy Emanuel Medical Center on December 16, 2020 in Portland, Oregon.
    Paula Bronstein/Getty Images
    Many independently-owned doctors offices say they don't have access to COVID-19 vaccines and have heard little from the federal or state governments about if or when they might receive doses.
    Hospitals, large retail pharmacies, and federally-qualified health centers are the main distributors of the vaccine, sources told Insider.
    So far, they've vaccinated nearly 9 million individuals in the US, according to the Centers...
    Read more ...

     

  • The COVID vaccine was developed in record time thanks to mRNA. Pfizer's CEO says the technology should now be used on other viral diseases like the flu

    15 days ago - By Business Insider

    The Pfizer Covid-19 vaccine. Dado Ruvic/Reuters
    Dado Ruvic/Reuters
    Covid-19 vaccine forwarded vaccine science years, Pfizer's CEO said, and now it's time to use advances for other viral diseases, such as the flu.
    "We'll be able to provide medical solutions for other devastating diseases," the CEO said.
    The Pfizer BioNTech vaccine used a new method with messenger RNA to initiate the immune response. Moderna's vaccine also used mRNA.
    Visit Business Insider's homepage for more stories .
    The Covid-19 immunization has advanced vaccine science by years, and now it's time to use those advances...
    Read more ...

     

  • Moderna CEO says data on the Covid-19 vaccine in young children likely won't be available until 2022

    15 days ago - By Business Insider

    A nurse prepares a coronavirus vaccine shot developed by the National Institutes of Health and Moderna Inc., July 2020. Hans Pennink/AP
    Hans Pennink/AP
    Data on Moderna's Covid-19 vaccine in young children won't be available until 2022, CEO says at JPMorgan Healthcare conference.
    The study will take longer because they have to start at a much lower dose.
    During the conference, Moderna said they are expecting to deliver between 600 million and 1 billion doses this year. In its presentation Tuesday, Pfizer said it's expecting to produce around 2 billion doses.
    Visit Business Insider's...
    Read more ...